Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,426 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group results.
Scilipoti P, Longoni M, de Angelis M, Zaurito P, Massiet A, Dutto D, Soria F, Álvarez-Maestro M, Bazán AA, Pradere B, Klatte T, Contieri R, Hurle R, Krajewski W, Subiela JD, Pichler R, Szostek A, Marcq G, Elena JLR, Aranda J, Gontero P, Rouprêt M, Shariat SF, Necchi A, Montorsi F, Briganti A, Xylinas E, Moschini M; EuroGemDoce Study Group Collaborators; European Association of Urology ‐ Young Academic Urologists (EAU‐YAU); Urothelial Carcinoma Working Group. Scilipoti P, et al. Among authors: de angelis m. BJU Int. 2025 Jan 11. doi: 10.1111/bju.16645. Online ahead of print. BJU Int. 2025. PMID: 39797535
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients.
Longoni M, Scilipoti P, Re C, Rosiello G, Nocera L, Pellegrino F, Basile G, de Angelis M, Quarta L, Burgio G, Necchi A, Cigliola A, Chiti A, Picchio M, Salonia A, Briganti A, Montorsi F, Moschini M. Longoni M, et al. Among authors: de angelis m. BJU Int. 2024 Oct;134(4):636-643. doi: 10.1111/bju.16363. Epub 2024 Apr 15. BJU Int. 2024. PMID: 38621771
The Role of Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
Scilipoti P, Ślusarczyk A, de Angelis M, Soria F, Pradere B, Krajewski W, D'Andrea D, Mari A, Giudice FD, Pichler R, Subiela JD, Afferi L, Albisinni S, Mertens L, Laukhtina E, Mori K, Radziszewski P, Shariat SF, Necchi A, Xylinas E, Gontero P, Rouprêt M, Montorsi F, Briganti A, Moschini M; European Association of Urology Young Academic Urologists Urothelial Carcinoma Working Group. Scilipoti P, et al. Among authors: de angelis m. Eur Urol Oncol. 2024 Dec;7(6):1293-1302. doi: 10.1016/j.euo.2024.06.005. Epub 2024 Jun 19. Eur Urol Oncol. 2024. PMID: 38902138 Review.
Implications for diagnosis and treatment strategies in non-muscle invasive bladder cancer with variant histology: a systematic review.
Basile G, de Angelis M, Leni R, Re C, Longoni M, Mari A, Soria F, Pradere B, Del Giudice F, Laukhtina E, D'Andrea D, Mori K, Krajewski W, Albisinni S, Gallioli A, Breda A, Esperto F, Briganti A, Montorsi F, Moschini M, Carando R; European Association of Urology - Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. Basile G, et al. Among authors: de angelis m. Minerva Urol Nephrol. 2023 Jun;75(3):278-288. doi: 10.23736/S2724-6051.23.05091-7. Epub 2023 Mar 22. Minerva Urol Nephrol. 2023. PMID: 36946716 Free article.
Long-term functional outcomes after robot-assisted radical cystectomy with intracorporeal ileal orthotopic neobladder.
Pellegrino F, Scilipoti P, Rosiello G, Longoni M, Leni R, Basile G, Quarta L, Zaurito P, Re C, de Angelis M, Cattafi F, Burgio G, Gandaglia G, Montorsi F, Briganti A, Moschini M. Pellegrino F, et al. Among authors: de angelis m. BJU Int. 2024 Jul;134(1):48-50. doi: 10.1111/bju.16337. Epub 2024 Mar 14. BJU Int. 2024. PMID: 38482772 No abstract available.
Trimodal therapy effect on survival in urothelial vs non-urothelial bladder cancer.
de Angelis M, Baudo A, Siech C, Jannello LMI, Di Bello F, Goyal JA, Tian Z, Longo N, de Cobelli O, Chun FKH, Saad F, Shariat SF, Carmignani L, Gandaglia G, Moschini M, Montorsi F, Briganti A, Karakiewicz PI. de Angelis M, et al. Among authors: de cobelli o. BJU Int. 2024 Oct;134(4):602-607. doi: 10.1111/bju.16333. Epub 2024 Mar 18. BJU Int. 2024. PMID: 38494989
Clinical Validation of the Intermediate-risk Non-muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group Collaboration.
Soria F, Rosazza M, Livoti S, Moschini M, De Angelis M, Giudice FD, Pichler R, Hurle R, Mancon S, Carrion DM, Krajewski W, Mertens LS, D'Andrea D, Mari A, Di Maida F, Dutto D, Colucci F, Casale G, Fertitta G, Laukhtina E, Albisinni S, Pradere B, Teoh JYC, Shariat SF, Briganti A, Kamat AM, Gontero P. Soria F, et al. Among authors: de angelis m. Eur Urol Oncol. 2024 Dec;7(6):1497-1503. doi: 10.1016/j.euo.2024.06.004. Epub 2024 Jun 20. Eur Urol Oncol. 2024. PMID: 38906794 Free article.
Mitomycin C vs. Bacillus Calmette-Guerin for treatment of intermediate-risk nonmuscle invasive bladder cancer patients-A comparative analysis from a single center.
Scilipoti P, Longoni M, de Angelis M, Re C, Bertini A, Cannoletta D, Burgio G, Lucianò R, Rosiello G, Colombo R, Gandaglia G, Salonia A, Montorsi F, Briganti A, Moschini M. Scilipoti P, et al. Among authors: de angelis m. Urol Oncol. 2024 Dec;42(12):451.e1-451.e10. doi: 10.1016/j.urolonc.2024.06.026. Epub 2024 Jul 26. Urol Oncol. 2024. PMID: 39060208
1,426 results